AML with Additional Cytogenetic Abnormalities to t(8: 21) has Poorer Survival than that with Isolated t(8;21): A Retrospective Multicenter Cohort Study

Journal Title: International Blood Research & Reviews - Year 2015, Vol 3, Issue 1

Abstract

Aim of the Study: To investigate the poor prognostic factors incriminated in AML with t (8; 21), particularly additional cytogenetic findings, clinicopathological presentation and their impact on survival rate in Egyptian and Saudi patients. Study Design: Patients were collected from three centers: 9 cases from King Abdullah Medical City in Makah, between 2010 and 2013, 16 from King Fahad Medical City in Riyadh, Saudi Arabia between 2007 and 2013 and 16 patients from National Cancer Institute, Cairo University, Egypt 2010 and 2013. Methodology: We studied 41 cases with t (8; 21). Immunophenotyping was performed using BD- FACS System. Conventional karyotypic analysis was done using standard culturing and banding techniques. Clinicopathological and cytogenetic data were correlated with disease outcome. Results: There was no statistically significant difference between Egyptian and Saudi patients concerning the hematological parameters or immunophenotype markers expression, Thirty four (82.9%) out of 41 patients achieved complete remission. The follow up period for the whole group ranged from 2.1 to 170.3 weeks. The median survival was 146 weeks. The overall survival rate was 80% at one year and 70% at two years. Regarding the cytogenetic profile 33/41(80.5%) had isolated t(8;21) and 8 patients (19.5%) had a chromosomal aberration in addition to t(8;21); the commonest of which was + 8 that was found in 5 patients. The median overall survival of those 8 patients was 28.4 compared to 146.7 weeks in cases with isolated t (8; 21) p=0.002. Also, they had a lower one year overall survival rate (44%) than those with isolated t (8; 21) (86%) and their two years overall survival was zero. Conclusion: AML associated with additional cytogenetic abnormalities to t (8;21) has poorer survival than that with isolated t(8;21). Trisomy 8 is mostly incriminated for this being the most commonly encountered in this study.

Authors and Affiliations

Nahla Ahmad Bahgat Abdulateef, Manar Mohammad Ismail, Soha Aly Elmorsy, Aziza F. ALswayyed, Essam Hamed Abdou, Omima Elemam

Keywords

Related Articles

Blood Group Phenotype Frequencies in Blood Donors in the Northeast of Democratic Republic of Congo

Background and Aims: To know blood group antigen frequencies in a population has various benefits as the assessing risk of alloimmunization, the providing antigen-negative compatible blood to patients with multiples anti...

Relationship between Glucose Level, Lipid Profiles, and Waist to Height Ratio (WHtR)

A cross sectional study was carried out to determine the relationship between glucose level, lipid profiles, and waist to height ratio (WHtR) among adults in a workplace setting. Respondents were recruited from governmen...

Level of Pentraxin-3 in Patients with Acute Leukemia in Septicemia and Its Prognostic Value

Introduction: In acute leukemia, sepsis is potentially fatal. Pentraxin3 is a protein rapidly produced in response to primary inflammatory signals. It shows high levels in sepsis, specially associated with vascular and e...

Cord Blood: A Review

The blood collected from a new born baby umbilical cord is known as Cord blood. It is a rich source of hemotopoietic stem cells, used in the treatment of over 80 diseases like various cancers and blood, immune and metabo...

JAK-2V617F Mutation in Acute Leukemia (South Egypt Experience)

Aim: To search for JAK2V617F mutation in patients with acute myeloid and acute lymphoblastic leukemia in south Egypt. Study Design: JAK2V617F mutation detected by amplification refractory mutation system (ARMS) -PCR. Pla...

Download PDF file
  • EP ID EP242415
  • DOI 10.9734/IBRR/2015/15529
  • Views 155
  • Downloads 0

How To Cite

Nahla Ahmad Bahgat Abdulateef, Manar Mohammad Ismail, Soha Aly Elmorsy, Aziza F. ALswayyed, Essam Hamed Abdou, Omima Elemam (2015). AML with Additional Cytogenetic Abnormalities to t(8: 21) has Poorer Survival than that with Isolated t(8;21): A Retrospective Multicenter Cohort Study. International Blood Research & Reviews, 3(1), 36-46. https://europub.co.uk/articles/-A-242415